EXELIXIS
Exelixis is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases. The majority of its programs focus on the discovery and development of small molecule drugs for cancer. The Company has a pipeline of compounds in various stages of development for the treatment of cancer and various metabolic, cardiovascular and inflammatory disorders. All of its development compounds were generated through its internal drug discovery activities, ... although it is developing certain of these compounds in collaboration with partners and has out-licensed to others. The Company is focusing its development activities on its clinical compounds, XL184, XL147 and XL765. XL184, the Company's advanced drug candidate, inhibits MET, VEGFR2 and RET, proteins that are key drivers of tumor growth and/or vascularization. XL147 is a selective inhibitor of PI3K while XL765 is a dual inhibitor of PI3K and mTOR.
EXELIXIS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1994-01-01
Address:
Alameda, California, United States
Country:
United States
Website Url:
http://www.exelixis.com
Total Employee:
251+
Status:
Active
Contact:
+1 6508378300
Total Funding:
379 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Font Awesome Wordpress Plugins
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2004-10-19 | X-Ceptor Therapeutics, Inc. | X-Ceptor Therapeutics, Inc. acquired by Exelixis | N/A |
| 2001-11-20 | Genomica S.A.U. | Genomica S.A.U. acquired by Exelixis | 110 M USD |
| 2001-04-23 | TaconicArtemis GmbH | TaconicArtemis GmbH acquired by Exelixis | N/A |
| 2000-09-08 | Agritope | Agritope acquired by Exelixis | 68 M USD |
| 1999-07-12 | Metaxen LLC | Metaxen LLC acquired by Exelixis | N/A |
Investors List
Deerfield
Deerfield investment in Post-IPO Debt - Exelixis
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Exelixis
Deerfield
Deerfield investment in Post-IPO Debt - Exelixis
PaineWebber
PaineWebber investment in Seed Round - Exelixis
Atlas Venture
Atlas Venture investment in Seed Round - Exelixis
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Seed Round - Exelixis
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-04 | Exelixis Appoints Vicki L. Goodman, M.D., as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer |
Official Site Inspections
http://www.exelixis.com Semrush global rank: 754.17 K Semrush visits lastest month: 53.31 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Exelixis"
Leadership Team l Exelixis
At Exelixis, we don’t simply have a mission, we are on a mission. This global ambition fuels our collaborative team committed to fulfilling our promise of oncology innovation excellence. By putting patient and employee needs at the …See details»
Exelixis - Wikipedia
Exelixis was founded in 1994; the scientific founders were Spyridon Artavanis–Tsakonas, at Yale at that time, and Corey Goodman and Gerry Rubin who were then at the University of …See details»
Advancing Science for Cancer Treatments l Exelixis
Exelixis is on a mission to help cancer patients recover stronger and live longer. Our Story. Cancer is our cause — make it yours too. Evolving cancer care begins with you. We offer purposeful career growth opportunities and a vibrant culture …See details»
Exelixis - Crunchbase Company Profile & Funding
Exelixis is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases. The majority of its programs focus on the discovery and …See details»
Org Chart Exelixis - The Official Board
The organizational chart of Exelixis displays its 21 main executives including Michael Morrissey, Chris Senner and Amy Peterson. Toggle navigation The Official Board. Search. Search. …See details»
Exelixis - Leadership Team - The Org
The Leadership Team at Exelixis is responsible for guiding the strategic direction of the company, ensuring alignment with its mission to develop innovative cancer therapies. This diverse group …See details»
Exelixis - The Org
Exelixis strives to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future.See details»
Welcome to the Exelixis Grants and Giving Portal
Please refer to the Exelixis - Grant Requestor Guide for details regarding the submission and processing of your proposal . For technical support, please contact SteepRock Client Services: …See details»
Exelixis - Regulatory and Compliance - The Org
The Regulatory and Compliance team at Exelixis ensures that the company's drug products meet all regulatory requirements and industry standards throughout the development and …See details»
Exelixis Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Exelixis has 5 employees at their 1 location and $2.17 b in annual revenue in FY 2024. See insights on Exelixis including office locations, competitors, revenue, financials, …See details»
Home | Exelixis
Exelixis offers lots of great resources to improve your life. Find out everything you need to know to take advantage of them. Learn More. Make Your Benefits Work for You. See how we’ve been …See details»
Exelixis | EXEL Stock Price, Company Overview & News - Forbes
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers …See details»
Building a Legacy of Oncology Excellence l Exelixis
The Exelixis story began in 1994 when our prominent team of founding scientists set out to use model system genetics to systematize drug discovery. This vision ultimately resulted in our …See details»
Exelixis Mission, Benefits, and Work Culture | Indeed.com
Come see what’s going on inside Exelixis, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make people want to work …See details»
Exelixis (LON:0IJO) Company Profile & Description - Stock Analysis
6 days ago Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The …See details»
Paid Time Off - Exelixis
Exelixis provides 25 hours of volunteer time off (VTO) for use toward volunteering during the work week with manager approval. You receive $20 in Volunteer Rewards (VR) for every hour …See details»
Exelixis' Leadership Team Team - Team members and org chart
The leadership team at Exelixis has a strong background in finance and molecular biology. They have held positions at large pharmaceutical companies such as Gilead Sciences and Wyeth …See details»
What is Exelixis? Company Culture, Mission, Values - Glassdoor
Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give patients and their families hope for the future. In this pursuit, we know our employees are our …See details»
Biotech Leader Exelixis Eyes Buy Point In Monday's Stock Market …
2 days ago Monday's IBD 50 Stocks To Watch pick is Exelixis (EXEL), which is just below a recent buy point in Monday's stock market rally. That makes Exelixis stock one of the best …See details»
Exelixis Announces U.S. FDA Approval of CABOMETYX ... - BioSpace
12 hours ago This press release contains forward-looking statements, including, without limitation, statements related to: the therapeutic potential of CABOMETYX for patients with …See details»